RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A new opportunity for the efficient synthesis of stable isotope labeled compounds
Ren, S., Fier, P. S., Ren, H., Hoover, A. J., Hesk, D., Marques, R., & Mergelsberg, I. (2018). S-34: A new opportunity for the efficient synthesis of stable isotope labeled compounds. Chemistry-A European Journal, 24(28), 7133-7136. https://doi.org/10.1002/chem.201801494
The synthesis of stable isotope labeled (SIL) complex drug molecules with >= 3 mass unit increase from the parent compound is essential for drug discovery and development. Typical approaches that rely on H-2, C-13, and N-15 isotopes can be very challenging or even intractable, and can delay the drug development process. This work introduces a new concept for the synthesis of labeled compounds that relies on the use of S-34. The synthetic utility of S-34 was demonstrated with the efficient synthesis of [S-34]phosphorothioates [S-34(2)]-PS-ODNs-TTT and [C-13, N-15, S-34]-ceftolozane. In addition, a procedure for the direct oxidation of phosphites to [S-34]phosphorothioates using elemental S-34 without isotope dilution was developed.
